María Victoria
Mateos Manteca
Fondazione IRCCS Istituto Nazionale dei Tumori
Milán, ItaliaPublications in collaboration with researchers from Fondazione IRCCS Istituto Nazionale dei Tumori (3)
2020
-
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR
Clinical Lymphoma, Myeloma and Leukemia, Vol. 20, Núm. 8, pp. 509-518
2013
-
Age and organ damage correlate with poor survival in myeloma patients: Meta-analysis of 1435 individual patient data from 4 randomized trials
Haematologica, Vol. 98, Núm. 6, pp. 980-987
2009
-
Plitidepsin is active in peripheral T-cell lymphoma: A subset analysis from an ongoing multicenter phase II trial
Haematologica Meeting Reports